HHSN261201400039C;SBIR TOPIC 326 DEVELOPMENT OF NOVEL THERAPEUTIC AGENTS THAT TARGET CANCER STEM CELLS;PROJECT TITLE: TARGETING BREAST CANCER STEM CELLS WITH PG-101;CONTRACT PERFORMANCE PERIOD 09/12/2

$224,997N43FY2014CANIH

Paganini Biopharma, Inc., Encino CA

Investigators

Gary Lazarcontact

Abstract

Targeting Breast cancer stem cells with PG-101

View original record on NIH RePORTER →

HHSN261201400039C;SBIR TOPIC 326 DEVELOPMENT OF NOVEL THERAPEUTIC AGENTS THAT TARGET CANCER STEM CELLS;PROJECT TITLE: TARGETING BREAST CANCER STEM CELLS WITH PG-101;CONTRACT PERFORMANCE PERIOD 09/12/2 · GrantIndex